Blacklisted
Medicines Food
Check a batch

Case file

Sresan Pharmaceuticals (Kancheepuram, Tamil Nadu)

Last checked 19 September 2026. Some details are still being verified.

Sresan Pharmaceuticals (Kancheepuram, Tamil Nadu)
All licences cancelled · plant sealedSresan Pharmaceuticals · Kancheepuram, Tamil Nadu

Sresan Pharmaceuticals, a small manufacturer in Kancheepuram, Tamil Nadu, produced Coldrif cough syrup, batch SR-13 of which contained diethylene glycol at 46 to 48.6 per cent and was linked to the deaths of 24 children in Madhya Pradesh and 3 in Rajasthan in September. October 2025. Tamil Nadu's drugs control authority cancelled all of the company's manufacturing licences and sealed the plant in October 2025. The owner, G. Ranganathan, was arrested on 9 October 2025; a medical representative became the sixth person arrested in August 2026; and the Enforcement Directorate raided seven Chennai locations and attached assets worth more than Rs 2 crore.

Status as of 19 September 2026

View primary recordReport a correction
Primary government sourceTier 1: government primary source

WHO Medical Product Alert N°5/2025: Substandard (contaminated) oral liquid medicines

CDSCO and state drug controllers · 13 October 2025

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Affected products and batches

ProductBatchNote
Coldrif SyrupSR-13DEG 46.28 to 48.6%
All other Sresan productsallLicences cancelled; withdrawn from market

Current status

No valid manufacturing licence; plant sealed; criminal prosecution and ED money-laundering proceedings ongoing as of 19 Sep 2026.

What to do if you have this product

Step 1

Do not use any product labelled Sresan Pharmaceuticals; all its licences are cancelled.

Step 2

Pharmacies holding Sresan stock should quarantine it and inform the state drug inspector.

Step 3

Parents whose child received Coldrif should keep the bottle and prescription for the investigation.

Official sources and primary records

Researched and written by The Blacklisted team
We are not doctors or pharmacists. Everything on this page comes from the documents listed above, which you can open and check. Last checked 19 September 2026. 2 details are still being confirmed against the original. Spotted a mistake? Tell us.